Wilkowska, Alina http://orcid.org/0000-0001-7258-6811
Cubała, Wiesław Jerzy
Article History
Accepted: 25 October 2022
First Online: 16 November 2022
Change Date: 2 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40261-022-01233-8
Declarations
:
: No funding was received to write this letter.
: Dr Alina Wilkowska has received research support from Biogen, Janssen-Cilag, Lundbeck, Polpharma, Sanofi. Prof. Wiesław J. Cubała has received research support from Acadia, Alkermes, Angelini, Auspex Pharmaceuticals, Celon, Cortexyme, Ferrier, GW Pharmaceuticals, Janssen, Minerva, NIH, NeuroCog, Otsuka, Servier, Sanofi.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Both authors conceived and wrote the letter.